Successful Educational Series Expanded to Reduce the Toll of COVID-19

Successful Educational Series Expanded to Reduce the Toll of COVID-19
Contact: Matt Miller
Phone: 646-336-6495
Fax: 646-336-6497
Email: [email protected]

NEW YORK (2/20/2023) – DKBmed LLC is launching a pair of new educational initiatives that address the needs of pharmacists and clinicians treating patients hospitalized with COVID-19. The two programs, entitled COVID-19: Keeping Up with a Moving Target for Hospital Pharmacists and COVID-19: Treatment Strategies for Hospitalized Patients, are the latest installations in DKBmed’s award-winning COVID-19 case-based programming which has reached over 25,000 clinicians.

Since late 2019, COVID-19 has led to 667 million infections and over 6.72 million deaths. Although worldwide uptake of effective vaccines has limited morbidity and mortality associated with COVID-19, the virus and its evolving variants continue to strain healthcare systems. According to the CDC, the 7-day daily average of new hospitalizations from December 28, 2022–January 3, 2023, was 6,519 in the United States. The most prevalent subvariant – XBB.1.5 – appears more transmissible than previous Omicron strains and demonstrates immune evasion properties.

“Over the last three years, researchers and healthcare professionals have made tremendous strides in treating COVID-19,” notes Dinora Chinchilla, MD, Health Sciences Assistant Clinical Professor at UC Irvine School of Medicine. “However, we must stay vigilant. It’s clear that there has been an uptick in cases and hospitalizations tied to XBB.1.5, and patients can still become seriously ill. Educational initiatives that help us better work as a team to improve patient outcomes are both appreciated and needed.”

COVID-19: Keeping Up with a Moving Target for Hospital Pharmacists will target hospital pharmacists, technicians, and other pharmacy decision-makers. Learners will receive bimonthly updates on the latest developments in COVID-19 treatment through three online activities. Pharmacy, hospital, and COVID-19 experts will also deliver supplemental insights to help participants improve their practice.

COVID-19: Treatment Strategies for Hospitalized Patients will offer hospitalists, nurses, ID physicians, pulmonologists, and others who treat patients with COVID-19 in the hospital setting an interactive educational experience. This new installment will feature:

  • A 30-minute enduring activity consisting of a lecture and case detailing a patient’s journey through diagnosis, hospitalization, and treatment for COVID-19
  • An expert-led, faculty discussion regarding best practices in the management of COVID-19
  • In-platform quizzes, learner tracking, and additional recommended resources for further reading

Credit Designation Statements

COVID-19: Keeping Up with a Moving Target for Hospital Pharmacists
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

COVID-19: Treatment Strategies for Hospitalized Patients

Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.5 contact hours.

Disclosure of Support

COVID-19: Keeping Up with a Moving Target for Hospital Pharmacists and COVID-19: Treatment Strategies for Hospitalized Patients are both supported by medical education grants from Gilead Sciences, Inc.

About DKBmed

DKBmed is an integrated continuing medical education company operated by an experienced team of medical education experts. DKBmed provides health care professionals with effective medical education that closes identified knowledge and practice gaps to improve patient health.

Working with accredited providers and other partners, DKBmed develops innovative educational programs and quality improvement (QI) initiatives, bringing new learning methodologies to the CME landscape. DKBmed has become a leader in QI in the independent medical education space with QI projects in Pain Management, HIV, Depression, Influenza, and Diabetic Eye Disease. DKBmed was also an early adopter of case scenarios with real patients and live actors, TED/DKBmed Talks, 3D animation, webcasts, podcasts, and smart phone applications for clinicians and patients. These forward-thinking approaches enable health care professionals to learn and access educational programs in a manner that is most convenient and appropriate for them.

DKBmed’s programs are accessible through the company’s website (www.dkbmed.com). They reach more than 150,000 health care professionals in primary care and in a variety of specialties and disease states including: HIV, COVID-19, cystic fibrosis, diabetes, influenza, dermatology, retinal disease, rheumatoid arthritis, COPD, asthma, multiple sclerosis, pain management, depression and viral hepatitis (HBV, HCV) and oncology.